SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zebra 365 who wrote (7308)4/20/1998 10:54:00 PM
From: Mkilloran  Read Replies (1) of 23519
 
Zebra.....If Bigkny3 had any question of Vivus management and sales of Muse then just look to the UK. Astra has done a great job generating $1.9 mill sales for Vivus in 4 1/2 weeks of sales in the 1st qtr.

Any est of how much ASTRA will sell in 2nd qtr...with supplies from the new factor???? How's $8 mill sound????

And Jansenn in Brazil, Argentina, S.Korea in the 3rd qtr???
Along with Astra in Switzerland in the 3rd qtr???

FDA approval of the new plant in the 2nd qtr will open up the world wide supply of Muse. More countries comming soon.

There should be a lot of happy people on this tread by the end of this year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News